QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Announces Participation in Upcoming H.C. Wainwright Bioconnect Conference
FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a life-sciences holding company dedicated to building a portfolio of assets and biotech solutions, will be involved in this month’s H.C. Wainwright Bioconnect Conference. The three-day conference is scheduled for Jan. 10–13, 2022. FSD Pharma interim CEO Anthony Durkacz will present at the conference; his presentation is scheduled for release on Jan. 10, 2022, at 7 a.m. ET, and will be available for conference attendees. Durkacz will also be available for one-on-one meetings with conference participants. To view the conference, visit https://ibn.fm/dqhxw To view the full press release, visit https://ibn.fm/411fV About FSD…